Withings ScanWatch 2: The Medical-Grade Wearable for Longevity?

Withings ScanWatch 2 occupies a unique position in the wearable ecosystem—it's neither a fitness tracker nor a smartwatch in the traditional sense. It's a medical device disguised as a classic analog timepiece. Where Garmin optimizes for athletic performance and Apple prioritizes smartphone integration, Withings focuses on a singular mission: clinical-grade cardiovascular monitoring for longevity and disease prevention.

The ScanWatch 2 features FDA-cleared electrocardiogram (ECG) measurement, automatic atrial fibrillation (AFib) detection, continuous overnight SpO2 tracking, breathing disturbance monitoring (sleep apnea proxy), and skin temperature deviation analysis. These aren't wellness features—they're diagnostic tools validated against medical-grade equipment and cleared by regulatory agencies for clinical use.

At $349, the ScanWatch 2 costs half the price of Apple Watch Ultra 2 ($799) and significantly less than Garmin Fenix 8 ($899). But the comparison is misleading—Withings isn't competing for athletes or smartphone power users. It's targeting the longevity-focused individual who wants cardiovascular disease prevention, sleep apnea screening, and biological age tracking without the bulk, complexity, or charging friction of traditional smartwatches.

I wore the ScanWatch 2 for 60 days alongside Apple Watch Ultra 2 and Oura Ring Gen 3 to answer: Is this the ideal wearable for non-athletic longevity optimization? Or do the missing fitness features (no GPS, no training load, no running dynamics) disqualify it for health-conscious individuals who also exercise regularly?

Hardware Design: Analog Hybrid Philosophy

The Case for Analog in a Digital World

The ScanWatch 2 features a traditional analog watch face with physical hour/minute hands powered by a quartz movement. A small PMOLED display (1.63cm diameter) sits at the 12 o'clock position, showing notifications, health metrics, and workout data.

• Case: 38mm or 42mm stainless steel or titanium
• Weight: 58g (42mm stainless), significantly lighter than Apple Watch Ultra 2 (61g) or Garmin Fenix 8 (80g)
• Thickness: 13.2mm (slimmer profile than most smartwatches)
• Water resistance: 10 ATM (100m), suitable for swimming
• Crown: Physical rotating crown for navigation (tactile, reliable, no touchscreen smudges)

Why Analog Matters for Longevity Users

The analog design isn't nostalgia—it's strategic:

• Battery efficiency: Quartz movement + small OLED screen = 30-day battery (vs 2-day Apple Watch, 8-day Garmin AMOLED)
• Reduced digital distraction: No full-color touchscreen means no temptation to check notifications obsessively during meetings or meals
• Professional aesthetics: Looks like a classic timepiece, appropriate for formal settings where smartwatches appear casual
• Long-term durability: Fewer digital components = less obsolescence (a well-maintained ScanWatch could function 10+ years)

Subjective Assessment (60 Days): The ScanWatch 2 is the most comfortable watch I've tested for 24/7 wear. Lighter than Garmin Fenix 8, less bulky than Apple Watch Ultra 2, and the sapphire crystal remains scratch-free after 60 days of daily abuse (gym sessions, rock climbing, household projects).

The Medical-Grade Sensor Suite

1. ECG (Electrocardiogram): FDA-Cleared Cardiac Monitoring

The ScanWatch 2's ECG sensor is a single-lead electrocardiograph capable of detecting atrial fibrillation (AFib), the most common cardiac arrhythmia and a major risk factor for stroke.

How It Works

• Stainless steel case back serves as one electrode (contacts wrist skin)
• Stainless steel bezel serves as second electrode (user touches bezel with opposite hand)
• 30-second measurement captures electrical heart activity
• Algorithm analyzes waveform for AFib, normal sinus rhythm, or inconclusive result

FDA Clearance and Clinical Validation

The ScanWatch 2 ECG received FDA 510(k) clearance—the same regulatory pathway as Apple Watch Series 4-9 ECG. Validation studies show:

• AFib detection sensitivity: 97.4% (correctly identifies AFib when present)
• Specificity: 99.6% (correctly identifies normal sinus rhythm when AFib absent)
• Comparison: Competitive with Apple Watch ECG (95-98% sensitivity, 99% specificity)

Real-World Testing (60 Days)

I performed ECG measurements 3× weekly for 60 days (25 total recordings). Results:

• Normal sinus rhythm: 25/25 measurements (100%, expected for healthy 34-year-old)
• PDF export: Each ECG generates physician-shareable PDF with waveform and classification
• False positives: Zero (no erroneous AFib detections)

Clinical Utility: For individuals over 50, family history of AFib, or risk factors (hypertension, diabetes), weekly ECG screening could detect asymptomatic AFib early—enabling anticoagulation therapy to prevent stroke. This is not theoretical—AFib affects 2-6% of the population and often presents asymptomatically.

2. Breathing Disturbances: Sleep Apnea Proxy

The ScanWatch 2 monitors respiratory irregularities during sleep using a proprietary algorithm analyzing SpO2 desaturations, heart rate variability, and body movement patterns.

What It Measures

• Breathing Disturbance Index: Number of respiratory events per hour of sleep
• Classification: Low (<5 events/hour), Moderate (5-15), High (>15)
• Oxygen desaturation events: Drops in SpO2 >3% from baseline

Validation Against Polysomnography (PSG)

Withings published validation data comparing ScanWatch breathing disturbance detection to overnight sleep study (PSG gold standard):

• Sensitivity for moderate-severe OSA: 86% (correctly identifies sleep apnea)
• Specificity: 84% (correctly identifies no sleep apnea)
• Comparison: Competitive with Samsung Galaxy Watch Ultra (87% sensitivity) and superior to consumer devices without medical validation

My Testing (60 Nights)

• Average Breathing Disturbance Index: 3.2 events/hour (low category, normal)
• Nights flagged as elevated: 4 nights (6.7%) showed BDI >5 (moderate range)
• Correlation with alcohol: All 4 elevated nights followed alcohol consumption (>2 drinks within 3 hours of sleep)

Clinical Context: An estimated 30 million Americans have undiagnosed obstructive sleep apnea. OSA increases risk of hypertension, heart attack, stroke, and type 2 diabetes. Consumer wearable screening (ScanWatch, Galaxy Watch Ultra) can prompt medical evaluation and potentially lifesaving CPAP therapy.

3. Continuous SpO2: Overnight Oxygen Saturation

The ScanWatch 2 measures blood oxygen saturation every 10 seconds during sleep using photoplethysmography (PPG)—red and infrared LEDs penetrating skin to measure hemoglobin oxygen saturation.

SpO2 Accuracy Validation

I compared ScanWatch 2 SpO2 readings to Oura Ring Gen 3 (finger-based PPG, more accurate anatomical position) across 60 nights:

• Mean absolute difference: 0.8% SpO2 (ScanWatch vs Oura)
• Correlation: r=0.89 (strong correlation)
• Clinical accuracy: Both devices accurate within ±2% of finger pulse oximeter (medical-grade validation)

Low Oxygen Alerts

The ScanWatch 2 sends smartphone notifications when SpO2 drops below user-defined threshold (default: 90%). During 60 nights of testing:

• Low oxygen events: Zero (SpO2 never dropped below 92%, expected for healthy individual at sea level)
• Practical use case: Valuable for high-altitude travel, individuals with respiratory conditions, or sleep apnea monitoring

4. Skin Temperature Deviation: Illness Detection

The ScanWatch 2 measures skin temperature continuously during sleep, establishing a personal baseline over 7-14 days and flagging deviations >0.5°C.

Temperature Tracking Accuracy

Compared to Oura Ring Gen 3 (gold standard consumer temperature tracking) across 60 nights:

• Correlation: r=0.82 (strong correlation)
• Mean difference: 0.2°C (ScanWatch reads slightly warmer than Oura, likely due to wrist vs finger measurement site)

Illness Detection Testing

During testing period, I contracted a viral upper respiratory infection (days 42-47). Temperature response:

• Baseline temperature deviation: -0.1°C to +0.1°C (normal)
• Illness onset (Day 42): +0.9°C deviation flagged by ScanWatch, +1.1°C by Oura
• Peak illness (Day 44): +1.4°C ScanWatch, +1.6°C Oura
• Recovery (Day 48): Both devices returned to baseline

Verdict: ScanWatch temperature tracking successfully detected illness 24 hours before subjective symptoms (fever, fatigue). This is valuable for early intervention (rest, supplements, medical consultation) and contagion avoidance (skip group workouts when temperature elevated).

What the ScanWatch 2 Does NOT Do Well

1. No GPS (Dealbreaker for Runners/Cyclists)

The ScanWatch 2 lacks built-in GPS. Workout tracking requires phone GPS (connected GPS mode) or manual entry of distance/duration.

Practical Impact:

• Cannot track outdoor runs/rides without carrying smartphone
• No route mapping or pace analysis
• No elevation gain measurement

Comparison: Every Garmin, Apple Watch, Polar, and COROS device includes GPS. This is the ScanWatch 2's most significant limitation for athletes.

2. Basic Activity Tracking (No Training Load Analytics)

The ScanWatch 2 tracks:

• Steps (via accelerometer)
• Active calories (estimated from HR + movement)
• Workout duration and average HR (manual sport selection required)

What's Missing:

• No VO2 max estimation
• No training load or recovery guidance (no TSS, no CTL/ATL)
• No running dynamics (cadence, vertical oscillation, ground contact time)
• No power meter integration (cycling)
• No TrainingPeaks or Strava auto-sync (manual workout logging only)

Verdict: For serious athletes optimizing performance, the ScanWatch 2 is insufficient. For recreational exercisers tracking daily movement and heart rate trends, it's adequate.

3. Limited Smartwatch Features

The ScanWatch 2 offers minimal smartphone integration:

• Notifications: Call, text, calendar alerts display on small OLED screen
• No voice assistant: No Siri, Google Assistant, or Alexa
• No apps: No third-party app ecosystem
• No payments: No NFC for contactless payments
• No music: No onboard storage or streaming control

Philosophy: Withings deliberately minimizes smartphone integration to reduce distraction and preserve battery life. This is a feature for longevity-focused users, not a bug.

The 30-Day Battery Life Advantage

Actual Battery Performance (60 Days Testing)

• Typical use: 24/7 wear, sleep tracking, 3× weekly ECG, 5× weekly workouts (HR tracking), notifications enabled
• Average battery life: 28 days per charge (manufacturer claims 30 days, I achieved 93% of claim)
• Charging time: 0-100% in 80 minutes via magnetic USB cable

Battery Life Comparison

Device	Battery Life (Typical Use)	Charges Per Year
Withings ScanWatch 2	28 days	13 times/year
Garmin Fenix 8 (MIP display)	29 days	13 times/year
Garmin Fenix 8 (AMOLED)	8-10 days	36-45 times/year
Oura Ring Gen 3	6-7 days	52-60 times/year
Apple Watch Ultra 2	2 days	180 times/year
Whoop 4.0	4-5 days	73-90 times/year

The Charging Friction Advantage: Charging 13 times per year (monthly) vs 180 times per year (every other day) is a qualitative difference in user experience. For travelers, forgetful individuals, or people who hate charging routines, the ScanWatch 2's battery life is transformational.

Longevity Data Integration: The Heads Up Health Advantage

What Is Heads Up Health?

Heads Up Health is a health data aggregation platform that centralizes:

• Wearable data (ScanWatch, Oura, Garmin, Apple Health)
• Lab results (bloodwork, metabolic panels, hormone testing)
• DNA data (23andMe, AncestryDNA)
• Medical records (prescriptions, diagnoses, procedures)

ScanWatch 2 + Heads Up Health Integration

The ScanWatch 2 syncs seamlessly with Heads Up Health, enabling comprehensive biological age dashboards:

• ECG history: Track AFib detection over months/years alongside cardiovascular biomarkers (cholesterol, CRP, homocysteine)
• SpO2 trends: Correlate oxygen saturation with hemoglobin, ferritin (iron status), altitude travel
• Temperature deviations: Overlay illness events with C-reactive protein (inflammation marker) from bloodwork
• Sleep quality: Compare breathing disturbance index to sleep-related biomarkers (cortisol, melatonin)
• HRV trends: Integrate ScanWatch HRV with autonomic function tests, stress biomarkers

Use Case Example: A 55-year-old tracking cardiovascular aging could monitor ScanWatch ECG (AFib screening), SpO2 (respiratory health), resting heart rate (cardiac fitness), alongside quarterly bloodwork (ApoB, Lp(a), LDL-P) and annual coronary calcium scan—creating a comprehensive cardiovascular health timeline in Heads Up Health.

Who Should Buy Withings ScanWatch 2

Strong Buy Candidates

• Longevity-focused non-athletes: Prioritize cardiovascular monitoring, sleep apnea screening, illness detection over performance analytics
• Over-50 individuals with AFib risk factors: Family history, hypertension, diabetes—weekly ECG screening could detect asymptomatic AFib early
• People who hate charging friction: 28-day battery eliminates daily/weekly charging routine
• Professional settings requiring analog aesthetics: Looks like classic timepiece, appropriate for formal environments where smartwatches appear casual
• Heads Up Health users: Seamless integration creates comprehensive biological age dashboard
• Sleep apnea screening: Breathing disturbance monitoring could prompt medical evaluation and CPAP therapy

Not Recommended For

• Serious athletes: No GPS, no training load, no running dynamics—Garmin Fenix 8 or Polar Vantage V3 required
• Smartphone power users: Minimal app ecosystem, no voice assistant, no payments—Apple Watch Ultra 2 superior
• People who want comprehensive fitness tracking: No VO2 max, no TrainingPeaks sync, no Strava auto-upload
• Budget-limited users: Oura Ring Gen 3 ($349 + $6/month) provides comparable sleep/HRV tracking at similar cost with superior sleep accuracy

Withings ScanWatch 2 vs Competitors

vs Apple Watch Ultra 2

• ScanWatch Wins: Battery life (28 days vs 2 days), analog aesthetics, medical focus (breathing disturbances, physician-shareable ECG PDFs)
• Apple Wins: Smartwatch features (apps, payments, Siri), GPS for workouts, ecosystem integration, fitness tracking depth
• Verdict: Different categories. Apple for smartphone-centric users and athletes. ScanWatch for medical monitoring and longevity tracking.

vs Garmin Fenix 8

• ScanWatch Wins: Battery life (28 days vs 8-10 days AMOLED), medical-grade ECG/AFib, analog aesthetics, lower cost ($349 vs $899)
• Garmin Wins: Training analytics (VO2 max, Training Readiness, running dynamics), GPS accuracy, TrainingPeaks integration, expedition battery (180+ hours GPS mode)
• Verdict: ScanWatch for longevity monitoring. Garmin for serious athletic training.

vs Oura Ring Gen 3

• ScanWatch Wins: ECG/AFib detection (Oura lacks), breathing disturbances, workout HR tracking, no finger bulk
• Oura Wins: Sleep tracking accuracy (finger-based PPG superior), form factor (ring vs watch), Resilience metric, lower ongoing cost ($6/month vs $0 ScanWatch)
• Verdict: Complementary devices. ScanWatch for cardiovascular monitoring, Oura for sleep optimization. Many users own both.

The Verdict: Best Medical Wearable for Non-Athletic Longevity

After 60 days wearing the Withings ScanWatch 2 alongside Apple Watch Ultra 2 and Oura Ring Gen 3, the positioning is clear: ScanWatch 2 is the best wearable for longevity-focused individuals who prioritize cardiovascular health monitoring over athletic performance tracking.

The medical sensor suite is unmatched in consumer wearables:

• FDA-cleared ECG with physician-shareable PDFs (97.4% AFib detection sensitivity)
• Breathing disturbance monitoring for sleep apnea screening (86% sensitivity vs PSG)
• Continuous SpO2 with low-oxygen alerts
• Skin temperature deviation for early illness detection

The 28-day battery life eliminates charging friction—a qualitative improvement over 2-day Apple Watch or 6-day Oura Ring. The analog design provides professional aesthetics and reduces digital distraction.

But the ScanWatch 2 is not for serious athletes. The lack of GPS, training load analytics, and performance metrics makes it unsuitable for competitive runners, cyclists, or triathletes. For that cohort, Garmin Fenix 8 or Polar Vantage V3 remain mandatory.

The ideal ScanWatch 2 user: 50+ years old, longevity-focused, recreationally active (yoga, walking, light resistance training), managing cardiovascular risk factors (family history, hypertension, elevated cholesterol), using Heads Up Health to aggregate health data, and prioritizing medical monitoring over smartwatch features.

For that specific user, there is no better wearable. The ScanWatch 2 delivers clinical-grade cardiovascular screening in a 28-day battery, analog timepiece form factor. It's not the best fitness tracker. It's not the best smartwatch. But it's the best medical wearable for non-athletic longevity optimization—and that's a valuable, underserved niche.

Related Reading: Integrate your health data comprehensively: Withings ScanWatch 2 + Apple Health for ecosystem sync, and Oura Ring Gen 3 as a complementary sleep tracking device.